In a surprising alliance, Health Secretary RFK Jr. praised President Trump for accomplishing what progressive Democrats have long promised but failed to deliver—taking on Big Pharma and slashing prescription drug prices. Kennedy declared that “no previous president has been as willing to confront oligarchs as Trump.” The Health Secretary criticized Bernie Sanders and AOC for failing to fulfill promises to lower drug prices.
Kennedy Praises Trump’s Bold Action on Drug Prices
Health and Human Services Secretary Robert F. Kennedy Jr. delivered a forceful endorsement of President Donald Trump following the signing of an executive order aimed at dramatically reducing prescription drug prices for Americans. Kennedy, a longtime critic of pharmaceutical industry influence, highlighted the significance of Trump’s action by contrasting it with unfulfilled promises from progressive Democratic leaders like Bernie Sanders and Alexandria Ocasio-Cortez, who have campaigned on similar issues for years without results.
“There has never been a president more willing to stand up to the oligarchs,” Kennedy declared during the White House announcement ceremony. The executive order is expected to lower prescription medication costs by 30% to 80% “almost immediately,” according to the administration. Kennedy emphasized that Trump’s willingness to take on powerful pharmaceutical interests demonstrates exceptional political courage in Washington’s lobbying-dominated environment.
Everything changed today.
This could go down as the biggest healthcare shift in American history.
Trump just did what every other politician promised to do but failed—he took a wrecking ball to Big Pharma.
An executive order to slash drug prices by up to 90%.
Then RFK Jr.… pic.twitter.com/Y8ZjwDwmRt
— The Vigilant Fox 🦊 (@VigilantFox) May 12, 2025
Failed Progressive Promises Exposed
Kennedy didn’t hold back in his criticism of prominent progressive politicians who have long promised to tackle high drug prices but failed to deliver. “This was the fulcrum of Bernie Sanders’ runs for presidency, that he was going to eliminate this discrepancy between Europe and the United States. As it turns out, none of them were doing it. It’s one of these promises that politicians make to their constituents, knowing that they’ll never have to do it,” Kennedy stated.
“This was an issue that people talked about. Nobody wanted to do anything because it was radioactive. They knew you couldn’t get it by Congress. We now have a president who is a man of his word.” Robert F. Kennedy Jr.
The Health Secretary pointed to the pharmaceutical industry’s powerful influence in Washington, noting the significant sums spent on lobbying Congress. This influence, Kennedy suggested, has prevented meaningful action on prescription drug prices despite years of campaign promises from politicians across the political spectrum. Trump’s executive order bypasses this congressional roadblock, delivering direct results to American consumers.
🇺🇸 Historic Trump/RFK Executive Order:#Pharma => downsizing subsidized drug pricing + “cutting out the middle men”.
1st president with the courage to recalibrate global drug costs to benefit from Favoured Nation pricing = US will pay whatever the lowest price is anywhere…#RFK pic.twitter.com/NgqNzbJxH5— Dr Astrid Stuckelberger (@Stuckelberger) May 12, 2025
A President “Who Can’t Be Bought”
In his remarks, Kennedy highlighted what he sees as a key difference between Trump and other politicians. “We now have a president who is a man of his word, who has the courage,” Kennedy said, adding that Trump “can’t be bought” by lobbyists or special interests. This independence, according to Kennedy, allows the president to take on entrenched powers in ways that other politicians either cannot or will not attempt.
The impact of the announcement extended beyond politics for Kennedy, who shared a personal reaction to the executive order. He expressed that even his children, who he described as Bernie Sanders supporters, were moved by Trump’s decisive action on an issue that has affected millions of American families struggling with high prescription costs. This bipartisan acknowledgment suggests the policy could resonate with voters across political lines.